Experts Matter. Find Yours.
Connect for media, speaking, professional opportunities & more.
Filters
Nilesh Gharge
Business HeadKeystone Center for Sleep Disorders
Business Head at Keystone Center for Sleep Disorders
Ramani Varanasi
President and CEOX-Biotix Therapeutics
Ramani Varanasi is a biopharmaceutical expert with experience structuring, negotiating and executing successful strategic alliances.
Professor Giampiero Favato
Director of the Institute of Leadership and Management in HealthKingston University
He examines the economics of public health policy - and in particular the economics of inequalities in accessing medical treatments.
Phil Tinmouth
Vice President & Head, Business Development & Alliance ManagementVertex Pharmaceuticals
Phil Tinmouth manages highly valuable and strategic collaborations in the biotechnology industry.
Mo Jiang, Ph.D.
Associate Professor, Department of Chemical and Life Science EngineeringVirginia Commonwealth University
Variability process intensification in material production & resource recovery, spanning healthcare, energy, & environmental sustainability
Steve Demas
Director, Clinical Operations Study LeadershipBiogen
Steve Demas is an expert in the pharmaceutical industry specializing in clinical trials, pharmaceutics, oncology and clinical monitoring.
Gerry Brunk
Managing DirectorLumira Ventures
Gerry Brunk is a venture capital investor with expertise in biotechnology, medical devices, start-ups and corporate strategy.
Mark Namchuk
Executive Director Therapeutics TranslationHarvard Medical School
Mark Namchuk works with scientists to identify and insights into clinical therapies, advancing scientific discoveries.
Rick Pierce
CEO and Co-founderSanaRx Biotherapeutics
Rick Pierce is a senior level executive and advisor, with expertise in attracting capital, forging transformative strategic alliances .
B. Frank Gupton, Ph.D.
Floyd D. Gottwald, Jr. Chair in Pharmaceutical Engineering; Chair, Professor, Department of Chemical and Life Science EngineeringVCU College of Engineering
Professor Gupton's research is focused on the development of new technologies that will streamline organic synthesis